Radiomic Pipelines for Prostate Cancer in External Beam Radiation Therapy: A Review of Methods and Future Directions.
Bruno MendesInês DominguesJoão SantosPublished in: Journal of clinical medicine (2024)
Background : Prostate Cancer (PCa) is asymptomatic at an early stage and often painless, requiring only active surveillance. External Beam Radiotherapy (EBRT) is currently a curative option for localised and locally advanced diseases and a palliative option for metastatic low-volume disease. Although highly effective, especially in a hypofractionation scheme, 17.4% to 39.4% of all patients suffer from cancer recurrence after EBRT. But, radiographic findings also correlate with significant differences in protein expression patterns. In the PCa EBRT workflow, several imaging modalities are available for grading, staging and contouring. Using image data characterisation algorithms (radiomics), one can provide a quantitative analysis of prognostic and predictive treatment outcomes. Methods : This literature review searched for original studies in radiomics for PCa in the context of EBRT. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, this review includes 73 new studies and analyses datasets, imaging modality, segmentation technique, feature extraction, selection and model building methods. Results : Magnetic Resonance Imaging (MRI) is the preferred imaging modality for radiomic studies in PCa but Computed Tomography (CT), Positron Emission Tomography (PET) and Ultrasound (US) may offer valuable insights on tumour characterisation and treatment response prediction. Conclusions : Most radiomic studies used small, homogeneous and private datasets lacking external validation and variability. Future research should focus on collaborative efforts to create large, multicentric datasets and develop standardised methodologies, ensuring the full potential of radiomics in clinical practice.
Keyphrases
- computed tomography
- positron emission tomography
- contrast enhanced
- magnetic resonance imaging
- prostate cancer
- early stage
- locally advanced
- high resolution
- meta analyses
- radiation therapy
- deep learning
- clinical practice
- case control
- systematic review
- dual energy
- machine learning
- squamous cell carcinoma
- diffusion weighted imaging
- pet ct
- lymph node metastasis
- end stage renal disease
- magnetic resonance
- rectal cancer
- small cell lung cancer
- healthcare
- neoadjuvant chemotherapy
- prognostic factors
- pet imaging
- quality improvement
- rna seq
- current status
- radical prostatectomy
- image quality
- health insurance
- chronic kidney disease
- papillary thyroid
- risk assessment
- climate change
- emergency department
- patient reported outcomes
- clinical trial
- photodynamic therapy
- adverse drug
- mass spectrometry
- big data
- weight loss
- newly diagnosed
- single cell
- contrast enhanced ultrasound
- fluorescence imaging